Brand Boost Guidelines

Feb 9, 2024
Download
Latest in Home
2025 01 08 Ssr2 Thumbnail
Theranostic pair ready for testing in lung cancer
January 8, 2026
Breast Screening Mammo
2025's budget bill could lead to more than 1M missed cancer screenings
January 8, 2026
Fda Logo V2 Social
LLMs in radiology may find opening in updated FDA guidance
January 8, 2026
2026 01 06 Aca Rad Chen Figure3 Thumbnail
Diffusion motion correction boosts portable brain CT image quality
January 7, 2026
Related Stories
Images obtained in a 50-year-old female patient with a new biopsy-proven malignant lesion in the left breast. (A) Craniocaudal mammogram of the right breast does not show any lesion. (B) The malignant lesion corresponds with a 7-cm irregular and spiculated mass on the left craniocaudal mammogram. Ultrasound-guided core-needle biopsy revealed grade 2 invasive lobular carcinoma. (C) The bilateral positron emission mammographic craniocaudal color image obtained one hour after intravenous injection of 185 MBq of F-18-labeled fluorodeoxyglucose (F-18 FDG) shows a mass with intense uptake in the left breast with known cancer and no abnormal uptake in the right breast. Positron emission mammographic craniocaudal images of the left breast obtained (D) one hour and (E) four hours after intravenous injection of 185 MBq of F-18 FDG show no substantial visual difference in uptake of the known cancer. (F) Axial contrast-enhanced fat-saturated subtracted T1-weighted MR image with maximum intensity projection reconstruction obtained 90 seconds after intravenous injection of 0.1 mmol of gadolinium-based contrast material per kilogram of body weight also shows the enhancing mass corresponding to known malignancy (arrow) and marked bilateral background parenchymal enhancement, with multiple nonspecific foci of enhancement in the contralateral breast. The patient opted for bilateral mastectomy, which confirmed left-sided malignancy and no malignancy in the contralateral breast. Image courtesy of the RSNA,
Womens Imaging
Low-dose PEM shows promise in breast cancer detection
Ambulance
Interventional
EVT valuable in patients requiring transit to stroke centers
Data analysis validation. Panel A: Image and line profile through the bottle on scans 1 (top) and 2 (middle), and the difference image (bottom) calculated according to Equation 3. Panel B: Data from a representative participant showing the effect of the dose correction on the PETWALK image using Equation 1 when applied to co-registered images in native subject space. The images were then warped to standard Montreal Neurological Institute (MNI) space Top: PETSTAND, middle – uncorrected PETWALK, bottom – corrected PETWALK. The color bar shows image intensity across the three images. Image courtesy of NeuroImage.
Molecular Imaging
PET reveals brain’s energy demands during walking
Artificial Intelligence Lung Color (1)
CT
AI boosts CTPA's ability to predict lung disease survival
More in Home
Theranostic pair ready for testing in lung cancer
By Will Morton
Gallium-68 (Ga-68) SSO120 PET/CT successfully visualized lesions in patients during and after chemotherapy.
January 8, 2026
2025 01 08 Ssr2 Thumbnail
2025's budget bill could lead to more than 1M missed cancer screenings
By Kate Madden Yee
The bill reduces Medicaid funding and could "disproportionately impact young and socially vulnerable enrollees," researchers wrote.
January 8, 2026
Breast Screening Mammo
LLMs in radiology may find opening in updated FDA guidance
By Liz Carey
The U.S. FDA has released updated guidance that could pave the way for wider use of large language models (LLMs) in radiology.
January 8, 2026
Fda Logo V2 Social
Diffusion motion correction boosts portable brain CT image quality
By Kate Madden Yee
The finding underscores the algorithm's potential for imaging severely ill patients with portable CT.
January 7, 2026
2026 01 06 Aca Rad Chen Figure3 Thumbnail
Lobular breast histology not strong predictor of SLNB positivity
By Amerigo Allegretto
Lobular histology is not a strong predictor of sentinel lymph node biopsy (SLNB) positivity in early-stage breast cancer cases.
January 7, 2026
Breast Imaging Computer Screen Thumbnail (1)
Algorithm demonstrates prediction accuracy for lung cancer risk
By Kate Madden Yee
Using lung cancer risk-prediction models at the screening stage helps identify high-risk individuals.
January 7, 2026
Lung Cancer
Clinical protocols help drive appropriate cervical spine CT use
By Will Morton
With the increased availability of cervical spine CT, it is essential to improve imaging decisions.
January 6, 2026
Emergency2
Lung cancer screening reporting reveals incidental finding risk classes
By Liz Carey
Researchers tracked seven prespecified "S modifiers," or clinically significant incidental findings.
January 6, 2026
Lung Cancer gno Av Jz1 Rj
GPT-4o bests radiologists for protocoling abdominal and pelvic CT scans
By Kate Madden Yee
The study findings could improve department workflow, allowing radiologists to focus on "core interpretive responsibilities."
January 6, 2026
Gpt 4o Hand Adobe Winexa
Adding endovascular recanalization does not improve sNAIAO treatment
By Amerigo Allegretto
Adding endovascular recanalization does not improve outcomes for symptomatic nonacute intracranial artery occlusion (sNAIAO).
January 6, 2026
2026 01 06 Radiology Endo Recanalization Brain Ct Thumbnail
LLMs help automate PI-RADS classification from MRI reports
By Kate Madden Yee
The study findings could translate to better patient care, as correct classification of prostate lesions is key to treatment.
January 5, 2026
Prostate Cancer 2
What are Pluvicto discontinuation rates in a real-world setting?
By Will Morton
There is a critical need to predict nonresponders and potential discontinuers prior to treatment.
January 5, 2026
Prostate Imaging
Page 1 of 194
Next Page